Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)

The rise in the incidence of nonalcoholic steatohepatitis (NASH) has necessitated the development of an effective prevention methodology. An antidiabetic drug, belonging to the group of sodium glucose cotransporter 2 (SGLT2) inhibitors, has been tested for its therapeutic effect on NASH; however, no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:FEBS Open Bio
Main Authors: Goto, Ryo, Kamimura, Kenya, Shinagawa‐Kobayashi, Yoko, Sakai, Norihiro, Nagoya, Takuro, Niwa, Yusuke, Ko, Masayoshi, Ogawa, Kohei, Inoue, Ryosuke, Yokoo, Takeshi, Sakamaki, Akira, Kamimura, Hiroteru, Abe, Satoshi, Nishina, Hiroshi, Terai, Shuji
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6443870/
https://ncbi.nlm.nih.gov/pubmed/30984539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12598
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados